Krebs Biochemicals & Industries
72.35
-0.75(-1.03%)
Market Cap₹155.99 Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-1.03%
1M-5.56%
6M-8.28%
1Y-13.00%
5Y-17.17%
View Company Insightsright
Latest news about Krebs Biochemicals & Industries
Krebs Biochemicals Reports Rs 532.43 Crore Loss in Q1, Appoints New MD & CEO Aug 08, 2025
Krebs Biochemicals & Industries reported a net loss of Rs 532.43 crore for Q1, with total income from operations at Rs 549.26 crore. The company appointed Mr. Manish Kumar Jain as the new Managing Director and CEO, replacing Mr. Jitendra Shah who resigned. The Board addressed a fine for non-compliance with SEBI regulations, stating it has been rectified with the appointment of new Independent Directors.
Krebs Biochemicals Appoints New MD & CEO, Announces Q1 Results Aug 07, 2025
Krebs Biochemicals Announces Q1 Results and Leadership Transition Aug 07, 2025
Krebs Biochemicals & Industries' MD & CEO Jitendra Shah Steps Down Jul 25, 2025